AAAAAA
Results: 1-25/26
Authors:
RITSCHEL WA
BHARAJ SS
Citation: Wa. Ritschel et Ss. Bharaj, THE FUTURE CLINICAL-TRIAL - COMPUTERIZED DATA MANAGEMENT, Methods and findings in experimental and clinical pharmacology, 20(6), 1998, pp. 517-526
Authors:
RITSCHEL WA
PAULOS C
ARANCIBIA A
AGRAWAL MA
WETZELSBERGER KM
LUCKER PW
Citation: Wa. Ritschel et al., URINARY-EXCRETION OF ACETAZOLAMIDE IN HEALTHY-VOLUNTEERS AFTER SHORT-TERM AND LONG-TERM EXPOSURE TO HIGH-ALTITUDE, Methods and findings in experimental and clinical pharmacology, 20(2), 1998, pp. 133-137
Authors:
RITSCHEL WA
PAULOS C
ARANCIBIA A
AGRAWAL MA
WETZELSBERGER KM
LUCKER PW
Citation: Wa. Ritschel et al., PHARMACOKINETICS OF ACETAZOLAMIDE IN HEALTHY-VOLUNTEERS AFTER SHORT-TERM AND LONG-TERM EXPOSURE TO HIGH-ALTITUDE, Journal of clinical pharmacology, 38(6), 1998, pp. 533-539
Authors:
PANCHAGNULA R
STEMMER K
RITSCHEL WA
Citation: R. Panchagnula et al., ANIMAL-MODELS FOR TRANSDERMAL DRUG-DELIVERY, Methods and findings in experimental and clinical pharmacology, 19(5), 1997, pp. 335-341
Authors:
FORUSZ H
RITSCHEL WA
Citation: H. Forusz et Wa. Ritschel, THE EFFECTS OF TRIETHANOLAMINE MYRISTATE, A FATTY-ACID SALT, ON THE AVAILABILITY OF RIBOFLAVIN IN HUMANS, Methods and findings in experimental and clinical pharmacology, 19(1), 1997, pp. 73-76
Authors:
RITSCHEL WA
Citation: Wa. Ritschel, MICROEMULSION TECHNOLOGY IN THE REFORMULATION OF CYCLOSPORINE - THE REASON BEHIND THE PHARMACOKINETIC PROPERTIES OF NEORAL, Clinical transplantation, 10(4), 1996, pp. 364-373
Authors:
FORUSZ H
RITSCHEL WA
Citation: H. Forusz et Wa. Ritschel, THE EFFECTS OF TRIETHANOLAMINE MYRISTATE, A FATTY-ACID SALT, ON THE BIOAVAILABILITY OF RIBOFLAVIN IN DOGS, Methods and findings in experimental and clinical pharmacology, 18(9), 1996, pp. 589-591
Authors:
RITSCHEL WA
PAULOS C
ARANCIBIA A
PEZZANI M
AGRAWAL M
WETZELSBERGER K
LUCKER PW
Citation: Wa. Ritschel et al., URINARY-EXCRETION OF MEPERIDINE AND NORMEPERIDINE IN MAN UPON ACUTE AND CHRONIC EXPOSURE TO HIGH-ALTITUDE, Methods and findings in experimental and clinical pharmacology, 18(1), 1996, pp. 49-53
Authors:
RITSCHEL WA
PAULOS C
ARANCIBIA A
PEZZANI M
AGRAWAL MA
WETZELSBERGER KM
LUCKER PW
Citation: Wa. Ritschel et al., PHARMACOKINETICS OF MEPERIDINE IN HEALTHY-VOLUNTEERS AFTER SHORT-TERMAND LONG-TERM EXPOSURE TO HIGH-ALTITUDE, Journal of clinical pharmacology, 36(7), 1996, pp. 610-616
Authors:
FRIDRIKSSON JH
RITSCHEL WA
IWAMOTO HS
Citation: Jh. Fridriksson et al., EFFECTS OF NEPHRECTOMY ON INSULIN-LIKE-GROWN-FACTOR-BINDING-PROTEIN-4(IGFBP-4) IN FETAL SHEEP, Pediatric research, 39(4), 1996, pp. 2145-2145
Authors:
CAVALLO A
RITSCHEL WA
Citation: A. Cavallo et Wa. Ritschel, PHARMACOKINETICS OF MELATONIN IN HUMAN SEXUAL-MATURATION, The Journal of clinical endocrinology and metabolism, 81(5), 1996, pp. 1882-1886
Authors:
RAO S
RITSCHEL WA
Citation: S. Rao et Wa. Ritschel, COLONIC DRUG-DELIVERY OF SMALL PEPTIDES, STP pharma sciences, 5(1), 1995, pp. 19-29
Authors:
RITSCHEL WA
AKILESWARAN R
HUSSAIN AS
Citation: Wa. Ritschel et al., APPLICATION OF NEURAL NETWORKS FOR THE PREDICTION OF HUMAN PHARMACOKINETIC PARAMETERS, Methods and findings in experimental and clinical pharmacology, 17(9), 1995, pp. 629-643
Authors:
RITSCHEL WA
SHAPIROJACOBSON M
AKILESWARAN R
WETZELSBERGER K
LUCKER PW
Citation: Wa. Ritschel et al., MEPERIDINE UPTAKE AND BINDING TO HUMAN BLOOD EX-VIVO, Methods and findings in experimental and clinical pharmacology, 17(7), 1995, pp. 477-481
Authors:
SATHYAN G
RITSCHEL WA
HUSSAIN AS
Citation: G. Sathyan et al., TRANSDERMAL DELIVERY OF TACRINE .1. IDENTIFICATION OF A SUITABLE DELIVERY VEHICLE, International journal of pharmaceutics, 114(1), 1995, pp. 75-83
Authors:
VATTIKONDA CS
RITSCHEL WA
HERBERT C
Citation: Cs. Vattikonda et al., BIOPHARMACEUTIC APPROACH IN DESIGNING A CONTROLLED-RELEASE TABLET OF SODIUM MONOFLUORO PHOSPHATE - CHARACTERIZATION OF ABSORPTION SITES ANDEVALUATION OF MODIFIED DOSAGE FORM, International journal of clinical pharmacology and therapeutics, 32(10), 1994, pp. 559-566
Authors:
RITSCHEL WA
FORUSZ H
Citation: Wa. Ritschel et H. Forusz, INTRODUCTION TO GENE TECHNOLOGY, Methods and findings in experimental and clinical pharmacology, 16(7), 1994, pp. 453-467
Authors:
CHENG CL
GEHRKE SH
RITSCHEL WA
Citation: Cl. Cheng et al., DEVELOPMENT OF AN AZOPOLYMER BASED COLONIC RELEASE CAPSULE FOR DELIVERING PROTEINS MACROMOLECULES/, Methods and findings in experimental and clinical pharmacology, 16(4), 1994, pp. 271-278
Authors:
RITSCHEL WA
FORUSZ H
Citation: Wa. Ritschel et H. Forusz, CHRONOPHARMACOLOGY - A REVIEW OF DRUGS STUDIED, Methods and findings in experimental and clinical pharmacology, 16(1), 1994, pp. 57-75
Authors:
TURKOGLU M
RITSCHEL WA
SAKR A
Citation: M. Turkoglu et al., IN-VIVO EVALUATION OF FLUIDIZED-BED COATED PELLETS, International journal of pharmaceutics, 103(2), 1994, pp. 115-118
Authors:
VATTIKONDA CS
RITSCHEL WA
Citation: Cs. Vattikonda et Wa. Ritschel, A BIOPHARMACEUTIC APPROACH IN DESIGNING A CONTROLLED-RELEASE TABLET OF SODIUM MONOFLUOROPHOSPHATE .1. IN-VITRO AND IN-VIVO STUDIES IN BEAGLE DOGS, Biopharmaceutics & drug disposition, 15(8), 1994, pp. 679-690
Authors:
MENON A
RITSCHEL WA
SAKR A
Citation: A. Menon et al., DEVELOPMENT AND EVALUATION OF A MONOLITHIC FLOATING DOSAGE FORM FOR FUROSEMIDE, Journal of pharmaceutical sciences, 83(2), 1994, pp. 239-245
Authors:
RITSCHEL WA
Citation: Wa. Ritschel, IDENTIFICATION OF POPULATIONS AT RISK IN DRUG-TESTING AND THERAPY - APPLICATION TO ELDERLY PATIENTS, European journal of drug metabolism and pharmacokinetics, 18(1), 1993, pp. 101-111
Authors:
DRESSMAN JB
BASS P
RITSCHEL WA
FRIEND DR
RUBINSTEIN A
ZIV E
Citation: Jb. Dressman et al., GASTROINTESTINAL PARAMETERS THAT INFLUENCE ORAL MEDICATIONS, Journal of pharmaceutical sciences, 82(9), 1993, pp. 857-872
Authors:
FASSIHI RA
RITSCHEL WA
Citation: Ra. Fassihi et Wa. Ritschel, MULTIPLE-LAYER, DIRECT-COMPRESSION, CONTROLLED-RELEASE SYSTEM - IN-VITRO AND IN-VIVO EVALUATION, Journal of pharmaceutical sciences, 82(7), 1993, pp. 750-754